RTW INVESTMENTS, LP - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 15 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q1 2022$1,349,000
-41.8%
446,564
-0.8%
0.03%
-17.6%
Q4 2021$2,318,000
-78.7%
450,0000.0%0.03%
-79.3%
Q3 2021$10,904,000
+24.1%
450,0000.0%0.16%
+23.3%
Q2 2021$8,789,000
+5.6%
450,0000.0%0.13%
+2.3%
Q1 2021$8,325,000450,0000.13%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$1,805,0000.60%
RA Capital Management 6,991,003$21,113,0000.46%
Ikarian Capital, LLC 677,859$2,047,0000.27%
Kynam Capital Management, LP 227,759$688,0000.22%
Octagon Capital Advisors LP 279,921$845,0000.18%
RTW INVESTMENTS, LP 446,564$1,349,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,437,500$4,341,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 77,851$235,0000.01%
JANUS HENDERSON GROUP PLC 1,599,826$4,807,0000.00%
CSS LLC/IL 20,000$60,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders